Journal of Cancer Research and Clinical Oncology
Published by Springer Nature
ISSN : 0171-5216 eISSN : 1432-1335
Abbreviation : J. Cancer Res. Clin. Oncol.
Aims & Scope
The Journal of Cancer Research and Clinical Oncology contains significant and up-to-date articles within the fields of experimental and clinical oncology.
The Journal, which is chiefly devoted to Original papers and Rapid communications (given priority treatment by the Editors), also includes Reviews as well as Editorials and Guest editorials on current, controversial topics.
The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest.
Meeting reports provide current information on the latest results presented at important congresses.
The following fields are covered: Carcinogenesis - etiology, mechanisms · Molecular biology · Recent developments in tumor therapy · General diagnosis · Laboratory diagnosis · Diagnostic and experimental pathology · Oncologic surgery · Epidemiology.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 2.8 |
2024 | 2.70 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.910 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 114 |
Journal Rank
Year | Value |
---|---|
2024 | 5601 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 6185 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,190.00 EUR. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten
Citation: 1323
Authors: H., R., S., D., J., G., H. D., M., P., H.
-
Randomized controlled trial of screening for hepatocellular carcinoma
Citation: 981
Authors: Bo-Heng, Bing-Hui, Zhao-You
-
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
Citation: 654
Authors: Rie, Tetsuya, Shinji, Masami, Kiyomi, Takatoshi, Wayne W., Hirota
-
Cancer active targeting by nanoparticles: a comprehensive review of literature
Citation: 620
Authors: Remon, Mohamad, Samar, Serag, Tamer
-
Radiation-induced fibrosis: mechanisms and implications for therapy
Citation: 497
Authors: Jeffrey M., Jacob, Chase D., Chris, Yelizaveta, Sufi M.
-
Inhibition of protein phosphatases by microcystis and nodularin associated with hepatotoxicity
Citation: 477
Authors: Shigeru, Rie, Mariyo F., Ken-ichi, Akira, Wayne W., Hirota
-
A decade?s studies on metastasis of hepatocellular carcinoma
Citation: 353
Authors: Zhao-You, Sheng-Long, Yin-Kun, Lun-Xiu, Hui-Chuan, Qin-Hai, Lu, Jian, Shuang-Jian, Yan, Xue-Ning, Hu, Jing-Ling, Zhi-Quan, Jia, Zeng-Chen, Xin-Da, Zhi-Ying, Kang-Da